Slide 1: 2nd Quarter Fiscal 2024 Earnings Conference Call Presentation
2nd Quarter Fiscal 2024 Earnings Conference Call Presentation February 7, 2024 | We shop. You save.
Slide 2: Disclaimer
Disclaimer Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use o
Slide 3: 2Q FY2024 Earnings
2Q FY2024 Earnings • Consolidated Company Highlights ◦ Increasing FY24 financial guidance midpoint for all $ in millions 2Q24 2Q23 % metrics Revenue $405.4 $319.2 +27% ◦ Two consecutive quarters of positive operating cash flow on an LTM basis Adjusted $67.4 $63.6 +6% EBITDA* ◦ On pace to deliver pos
Slide 4: 8th Consecutive Quarter Delivering Strong Results
8th Consecutive Quarter Delivering Strong Results Close Rates Agent Productivity AEP by the Numbers +97% +54% MA Policies (YoY) 7% Senior Revenue (YoY) 11% Senior Adjusted 32% EBITDA Margin* Tenured Agent Mix ~70% 2Q22 2Q23 2Q24 2Q22 2Q23 2Q24 *See "Non-GAAP Financial Measures" above on slide 2. | W
Slide 5: Senior Efficiency Metrics
Senior Efficiency Metrics Operating Expense Marketing Expense Revenue/CAC*** Per Policy* Per Policy** 4.2 $1,134 $661 3.0 $799 $776 $420 $411 1.8 LTM LTM LTM LTM LTM LTM LTM LTM LTM 12/31/21 12/31/22 12/31/23 12/31/21 12/31/22 12/31/23 12/31/21 12/31/22 12/31/23 *Represents Senior operating costs di
Slide 6: FY24 Healthcare Services Outlook
FY24 Healthcare Services Outlook Members 000s 69-74 Revised Guidance Range 2H 61 63 Outlook Original Revised Guidance* Guidance 49 YTD Member Growth 25% 40 - 50% Actuals ~$375m $450m - $500m Total Revenue (+50%) (+80 - 100%) Adjusted Low Single Low Single EBITDA** Margins Digits Digits FY23 Original
Slide 7: Consolidated Financial Summary
Consolidated Financial Summary Revenue Adjusted EBITDA* $MM $MM $405 $67 $64 $319 2Q23 2Q24 2Q23 2Q24 *See "Non-GAAP Financial Measures" above on slide 2. | We shop. You save. 7
Slide 8: Senior Financial Summary
Senior Financial Summary Revenue Adjusted EBITDA* $MM $MM $248 $84 $79 $224 2Q23 2Q24 2Q23 2Q24 *See "Non-GAAP Financial Measures" above on slide 2. | We shop. You save. 8
Slide 9: SelectQuote Senior KPIs
SelectQuote Senior KPIs Total Policies Approved MA LTV 000s MA Other $934 255 $870 241 20 22 235 219 2Q23 2Q24 2Q23 2Q24 | We shop. You save. 9
Slide 10: Healthcare Services KPIs
Healthcare Services KPIs SELECTRX Members Revenue & Adjusted EBITDA* 70,000 $MM 65,000 60,000 55,000 $112 50,000 $97 $83 45,000 $71 $55 40,000 35,000 30,000 2Q23 3Q23 4Q23 1Q24 2Q24 25,000 20,000 $2 $2 $3 15,000 $(3) 10,000 $(9) 5,000 — 2Q23 3Q23 4Q23 1Q24 2Q24 Revenue Adjusted EBITDA* *See "Non-GAA
Slide 11: Rapid SelectRx Prescription Growth
Rapid SelectRx Prescription Growth Rx per Day* Monthly Rx per Member 000s 18 +76% 7.0 6.8 15 +12% 6.5 12 6.3 9 6.0 5.8 6 5.5 3 5.3 — 5.0 2Q23 2Q24 2Q23 2Q24 *Represents the total number of prescriptions shipped during the quarter divided by the number of business days in the quarter. | We shop. You
Slide 12: Life and Auto & Home
Life and Auto & Home Revenue Adjusted EBITDA* $MM $MM $10 $8 $2 $5 $34 $37 $6 $5 2Q23 2Q24 2Q23 2Q24 Life Auto & Home Life Auto & Home *See "Non-GAAP Financial Measures" above on slide 2. | We shop. You save. 12
Slide 13: Revised FY24 Financial Guidance
Revised FY24 Financial Guidance REVENUE $1.23B to $1.30B +26% YoY At the Midpoint from $1.05 billion to $1.20 billion* ADJUSTED EBITDA** $90m to $105m +31% YoY At the Midpoint from $80 million to $105 million* NET LOSS ($45)m to ($22)m +43% YoY At the Midpoint from $(50) million to $(22) million* *O
Slide 14: Supplemental Information
Supplemental Information | We shop. You save. 14
Slide 15: Net Loss to Adjusted EBITDA Reconciliation
Net Loss to Adjusted EBITDA Reconciliation 2Q FY 2024 Healthcare (in thousands) Senior Services Life Auto & Home Corp & Elims Consolidated Revenue $ 247,529 $ 111,710 $ 37,367 $ 10,487 $ (1,655) $ 405,438 Operating expenses (168,816) (108,729) (32,798) (5,762) (21,919) (1) (338,024) Other income (ex
Slide 16: Net Loss to Adjusted EBITDA Reconciliation (FY24 Guidance)
Net Loss to Adjusted EBITDA Reconciliation (FY24 Guidance) (in thousands) Range Net loss $ (45,000) $ (22,000) Income tax benefit (8,000) (4,000) Interest expense, net 97,000 92,000 Depreciation and amortization 24,000 22,000 Share-based compensation expense 15,000 12,000 Non-recurring expenses 7,00
Slide 17: SelectQuote Inc. Investor Relations contact
SelectQuote Inc. 6800 West 115th Street Suite 2511 Overland Park, Kansas 66211 Phone: (913) 599-9225 Investor Relations investorrelations@selectquote.com | We shop. You save. 17